BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Holzer LA, Cör A, Pfandlsteiner G, Holzer G. Expression of VEGF, its receptors, and HIF-1α in Dupuytren's disease. Acta Orthop 2013;84:420-5. [PMID: 23992143 DOI: 10.3109/17453674.2013.814011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhang YC, Li XM, Yu Z, Shi XL, Li Y, Wang WL. Efficacy of pEgr-1-endostatin combined with ionizing radiation on hypoxic conditions in nude mice bearing SKOV3 ovarian carcinoma. Oncol Lett 2017;13:1101-8. [PMID: 28454220 DOI: 10.3892/ol.2017.5559] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Novotny T, Eckhardt A, Knitlova J, Doubkova M, Ostadal M, Uhlik J, Musilkova J. Increased Microvessel and Arteriole Density in the Contracted Side of the Relapsed Clubfoot. J Pediatr Orthop 2020;40:592-6. [PMID: 32379245 DOI: 10.1097/BPO.0000000000001563] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Shchudlo N, Varsegova T, Stupina T, Dolganova T, Shchudlo M, Shihaleva N, Kostin V. Assessment of palmar subcutaneous tissue vascularization in patients with Dupuytren’s contracture. World J Orthop 2018; 9(9): 130-137 [PMID: 30254969 DOI: 10.5312/wjo.v9.i9.130] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Holzer LA, Cör A, Holzer G. Expression of gap junction proteins connexins 26, 30, and 43 in Dupuytren's disease. Acta Orthop 2014;85:97-101. [PMID: 24359029 DOI: 10.3109/17453674.2013.871138] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Hou L, Zhang J, Zhang C, Xu Y, Zhu X, Yao C, Liu Y, Li T, Cao J. The injury of fine particulate matter from cooking oil fumes on umbilical cord blood vessels in vitro. Environmental Toxicology and Pharmacology 2017;49:65-73. [DOI: 10.1016/j.etap.2016.11.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
6 Musumeci M, Vadalà G, Russo F, Pelacchi F, Lanotte A, Denaro V. Dupuytren's disease therapy: targeting the vicious cycle of myofibroblasts? Expert Opin Ther Targets 2015;19:1677-87. [PMID: 26690790 DOI: 10.1517/14728222.2015.1068758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Meng ZY, Kang HL, Duan W, Zheng J, Li QN, Zhou ZJ. MicroRNA-210 Promotes Accumulation of Neural Precursor Cells Around Ischemic Foci After Cerebral Ischemia by Regulating the SOCS1-STAT3-VEGF-C Pathway. J Am Heart Assoc 2018;7:e005052. [PMID: 29478968 DOI: 10.1161/JAHA.116.005052] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
8 Bianchi E, Taurone S, Bardella L, Signore A, Pompili E, Sessa V, Chiappetta C, Fumagalli L, Di Gioia C, Pastore FS, Scarpa S, Artico M. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy? Clin Sci (Lond) 2015;129:711-20. [PMID: 26201022 DOI: 10.1042/CS20150088] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
9 Guo H, Zhou H, Lu J, Qu Y, Yu D, Tong Y. Vascular endothelial growth factor: an attractive target in the treatment of hypoxic/ischemic brain injury. Neural Regen Res 2016;11:174-9. [PMID: 26981109 DOI: 10.4103/1673-5374.175067] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]